lucky for them im still chasing that truth
not so lucky for corrupted code and lies everywhere when i know what i know and can tell when im being lied to
radar recordings are fucked beyond help
BACKGROUND
No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.
METHODS
We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fraction of inspired oxygen (Fio2) of less than 300 mm Hg. Patients were randomly assigned in a 1:1 ratio to receive either lopinavir–ritonavir (400 mg and 100 mg, respectively) twice a day for 14 days, in addition to standard care, or standard care alone. The primary end point was the time to clinical improvement, defined as the time from randomization to either an improvement of two points on a seven-category ordinal scale or discharge from the hospital, whichever came first.
RESULTS
A total of 199 patients with laboratory-confirmed SARS-CoV-2 infection underwent randomization; 99 were assigned to the lopinavir–ritonavir group, and 100 to the standard-care group. Treatment with lopinavir–ritonavir was not associated with a difference from standard care in the time to clinical improvement (hazard ratio for clinical improvement, 1.24; 95% confidence interval [CI], 0.90 to 1.72). Mortality at 28 days was similar in the lopinavir–ritonavir group and the standard-care group (19.2% vs. 25.0%; difference, −5.8 percentage points; 95% CI, −17.3 to 5.7). The percentages of patients with detectable viral RNA at various time points were similar. In a modified intention-to-treat analysis, lopinavir–ritonavir led to a median time to clinical improvement that was shorter by 1 day than that observed with standard care (hazard ratio, 1.39; 95% CI, 1.00 to 1.91). Gastrointestinal adverse events were more common in the lopinavir–ritonavir group, but serious adverse events were more common in the standard-care group. Lopinavir–ritonavir treatment was stopped early in 13 patients (13.8%) because of adverse events.
https://www.nejm.org/doi/full/10.1056/NEJMoa2001282
whats the craziest thing yall seen in the last month?
cause ive seen a fucking LOT and people getting the sniffles AINT it
posted it couple nights ago
only so many things people can say without jeopardizing forward action
also just out of respect
anyone catch the rally while back with a dozen or so slitherin house-esque ladies standing behind POTUS? (no offense, got that comment from someone else, but was accurate enough)
wait til things start turning gold and sacred symbol sealed looking like christmas
majority of most parts of most US defense systems weapons and electronics all manufactured in china.
between that and general dynamics / raytheon / mitre etc chokehold on the industry this war has been going on much long than most think
on a lighter note foreign relations are beautiful
irradiate me anyday